Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ALDEYRA-THERAPEUTICS-INC-16253115/news/Aldeyra-Therapeutics-Inc-Enrolls-First-Patient-in-Phase-3-Clinical-Trial-Designed-to-Enable-Potent-46664097/?utm_source=whatsapp&utm_medium=social&utm_campaign=share